Dynavax Technologies (DVAX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
13.82 +0.20 (+1.47%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 13.82 unch (unch) 16:44 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 277,246 | 232,284 | 722,683 | 439,442 | 46,551 |
Cost of Goods | 49,445 | 50,167 | 262,153 | 173,572 | 11,410 |
Gross Profit | 227,801 | 182,117 | 460,530 | 265,870 | 35,141 |
Operating Expenses | 232,368 | 219,312 | 177,161 | 131,956 | 103,922 |
Operating Income | -4,122 | -37,028 | 283,522 | 134,486 | -68,371 |
Interest Expense | 6,794 | 6,757 | 6,732 | 11,176 | 19,062 |
Other Income | 41,771 | 39,418 | 17,509 | -45,789 | 12,193 |
Pre-tax Income | 30,855 | -4,367 | 294,299 | 77,521 | -75,240 |
Income Tax | 3,546 | 2,022 | 1,143 | 808 | 0 |
Net Income Continuous | 27,309 | -6,389 | 293,156 | 76,713 | -75,240 |
Net Income | $27,309 | $-6,389 | $293,156 | $76,713 | $-75,240 |
EPS Basic Total Ops | 0.21 | -0.05 | 2.32 | 0.62 | -0.75 |
EPS Basic Continuous Ops | 0.21 | -0.05 | 2.32 | 0.66 | -0.75 |
EPS Diluted Total Ops | 0.20 | -0.05 | 1.97 | 0.57 | -0.78 |
EPS Diluted Continuous Ops | 0.20 | -0.05 | 1.94 | 0.58 | -0.74 |
EPS Diluted Before Non-Recurring Items | 0.20 | -0.05 | 1.97 | 0.87 | -0.61 |
EBITDA(a) | $-10,615 | $-46,307 | $286,009 | $142,014 | $-58,501 |